Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02673996

POTS Adrenergic Ab (CIHR Aims #1&2)

Sponsor: University of Calgary

View on ClinicalTrials.gov

Summary

Objective: In this pilot study, we will test the hypothesis that patients with POTS (age 18-60 years) will have a higher percentage of functional antibodies to adrenergic receptors compared with control subjects without POTS.

Official title: The Pathophysiological Role of Adrenergic Antibodies in Postural Tachycardia Syndrome (Aims #1&2)

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

OBSERVATIONAL

Enrollment

125

Start Date

2016-01

Completion Date

2027-12

Last Updated

2025-03-25

Healthy Volunteers

Yes

Interventions

DRUG

Phenylephrine

incremental small doses of IV phenylephrine to find the dose that transiently raises systolic blood pressure by 25 mmHg

DRUG

Isoproterenol

incremental small doses of IV isoproterenol to find the dose that transiently raises heart rate by 25 bpm

Locations (1)

University of Calgary

Calgary, Alberta, Canada